Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MLYCD | O95822 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 3/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1709282 | 0.80 | MEN1 (0.48) | ALDH1A1MLYCDEPHX2KDM4ETDP1 | |
| SCHEMBL947583 | 0.78 | CASP2 (0.48) | MLYCDEPHX2HDAC3HDAC1HDAC2 | |
| SCHEMBL25835504 | 0.78 | TDP1 (0.42) | KDM4EL3MBTL1CNR2TDP1POLB | |
| SCHEMBL26032884 | 0.77 | TDP1 (0.41) | KDM4EL3MBTL1CNR2TDP1GAA | |
| SCHEMBL13991902 | 0.77 | EPHX2 (0.39) | CNR1ALDH1A1EPHX2OXER1TDP1 | |
| SCHEMBL4810925 | 0.76 | TDP1 (0.41) | ALDH1A1MLYCDCTSKEPHX2HDAC3 | |
| SCHEMBL4810916 | 0.76 | MLYCD (0.40) | ALDH1A1MLYCDCTSKEPHX2HDAC3 | |
| SCHEMBL15131729 | 0.76 | MEN1 (0.44) | CTSKKDM4EL3MBTL1TDP1POLB | |
| SCHEMBL23631428 | 0.75 | MLYCD (0.39) | ALDH1A1MLYCDCTSKEPHX2HDAC3 | |
| SCHEMBL16761792 | 0.75 | ECE1 (0.41) | ALDH1A1MLYCDEPHX2KDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9029548-B2 | Fatty acid lenalidomide derivatives and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| US-20120283292-A1 | FATTY ACID LENALIDOMIDE AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2012-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283292-A1 | FATTY ACID LENALIDOMIDE AND THEIR USES | ELOVL1, FASN, FFAR2 | CNR1 2967/4885ALDH1A1 794/4885MLYCD 412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.